文献速递冠心病

PCI前心绞痛验证的N-of-1试验:ORBITA-STAR研究

N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention.
PubMed 文献 · J Am Coll Cardiol · 2024-05-14

BACKGROUND: In stable coronary artery disease, 30% to 60% of patients remain symptomatic despite successful revascularization. Perhaps not all symptoms reported by a patient with myocardial ischemia are, in fact, angina.…

要点

  • 症状相似度评分可区分哪些患者从PCI获得最大症状缓解。
  • 上四分位相似度评分5.25者随访心绞痛频率显著低于低四分位0.875者。
  • 该独立症状验证方法为靶向PCI获益人群奠定基础。

核心结论

  • 症状相似度评分强预测PCI后症状改善,支持独立症状映射以靶向最可能获益的患者。

主要发现

  • 中位FFR为0.68(Q1-Q3:0.57-0.79),瞬时无波形比率为0.80(Q1-Q3:0.48-0.89),中位相似度评分为3(Q1-Q3:0.875-5.25)。
  • 上四分位相似度评分5.25的患者随访时心绞痛频率更低(OR:8.01;95%可信区间:2.39-15.86),较低四分位评分0.875者(OR:1.31;95%可信区间:0.71-1.99),Pr(difference)>99.9%。

临床怎么用

  • 对稳定冠心病患者,PCI前可采用安慰剂对照的缺血刺激进行独立症状验证,以识别最可能从PCI获得症状缓解者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In stable coronary artery disease, 30% to 60% of patients remain symptomatic despite successful revascularization. Perhaps not all symptoms reported by a patient with myocardial ischemia are, in fact, angina. OBJECTIVES: This study sought to determine whether independent symptom verification using a placebo-controlled ischemic stimulus could distinguish which patients achieve greatest symptom relief from percutaneous coronary intervention (PCI). METHODS: ORBITA-STAR was a multicenter, n-of-1, placebo-controlled study in patients undergoing single-vessel PCI for stable symptoms. Participants underwent 4 episodes (60 seconds each) of low-pressure balloon occlusion across their coronary stenosis, randomly paired with 4 episodes of placebo inflation. Following each episode, patients reported the similarity of the induced symptom in comparison with their usual symptom. The similarity score ranged from -10 (placebo replicated the symptom more than balloon occlusion) to +10 (balloon occlusion exactly replicated the symptom). The primary endpoint was the ability of the similarity score to predict symptom relief with PCI. RESULTS: Fifty-one patients were recruited, aged 62.9 ± 8.6 years. The median fractional flow reserve was 0.68 (Q1-Q3: 0.57-0.79), and the instantaneous wave-free ratio was 0.80 (Q1-Q3: 0.48-0.89). The median similarity score was 3 (Q1-Q3: 0.875-5.25). The similarity score was a strong predictor of symptom improvement following PCI: a patient with an upper quartile similarity score of 5.25 was significantly more likely to have lower angina frequency at follow-up (OR: 8.01; 95% credible interval: 2.39-15.86) than a patient with a lower quartile similarity score of 0.875 (OR: 1.31; 95% credible interval: 0.71-1.99), Pr(difference) >99.9%. CONCLUSIONS: Similarity score powerfully predicted symptom improvement from PCI. These data lay the foundation for independent symptom mapping to target PCI to those patients most likely to benefit. (Systematic Trial of Angina Assessment Before Revascularization [ORBITA-STAR]; NCT04280575).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Rajkumar CA, Foley MJ, Ahmed-Jushuf F, et al. N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention. J Am Coll Cardiol. 2024. PMID: 38752902. doi:10.1016/j.jacc.2024.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。